Company Name: |
Adamas Reagent, Ltd.
|
Tel: |
400-6009262 16621234537 |
Email: |
chenyj@titansci.com |
Products Intro: |
Product Name:(3E)-2,3-Dihydro-3-[(3-Hydroxy-4-Methoxyphenyl)Methylene]-6-Methyl-4H-1-Benzopyran-4-One CAS:1031206-36-6 Purity:97% Package:100mg;250mg;1g
|
Company Name: |
Tianjin Kailiqi Biotechnology Co., Ltd.
|
Tel: |
15076683720 |
Email: |
klq@cw-bio.com |
Products Intro: |
Product Name:IMS2186 CAS:1031206-36-6 Purity:大于98% Package:1g,5g,10g,25g根据客户需要分装 Remarks:Not For Human Use, Lab Use Only.
|
Company Name: |
BOC Sciences
|
Tel: |
|
Email: |
info@bocsci.com |
Products Intro: |
Product Name:IMS 2186 CAS:1031206-36-6 Purity:99% Remarks:IMS 2186 is an anti-proliferative and anti-angiogenic compound developed as an anti-choroidal neovascularization (anti-CNV) drug. It inhibits the cell cycle at G2 and the production of PGE2/TNF-α.
|
3-[1-(3-Hydroxy-4-methoxyphenyl)-meth-(E)-ylidene]-6-methyl-chroman-4-one manufacturers
- IMS2186
-
- $38.00 / 5mg
-
2024-10-31
- CAS:1031206-36-6
- Min. Order:
- Purity: 99.79%
- Supply Ability: 10g
|
| 3-[1-(3-Hydroxy-4-methoxyphenyl)-meth-(E)-ylidene]-6-methyl-chroman-4-one Basic information |
Product Name: | 3-[1-(3-Hydroxy-4-methoxyphenyl)-meth-(E)-ylidene]-6-methyl-chroman-4-one | Synonyms: | 3-[1-(3-Hydroxy-4-methoxyphenyl)-meth-(E)-ylidene]-6-methyl-chroman-4-one;IMS2186;4H-1-Benzopyran-4-one, 2,3-dihydro-3-[(3-hydroxy-4-methoxyphenyl)methylene]-6-methyl-, (3E)-;(E)-3-(3-Hydroxy-4-methoxybenzylidene)-6-methylchroman-4-one;(3E)-2,3-Dihydro-3-[(3-Hydroxy-4-Methoxyphenyl)Methylene]-6-Methyl-4H-1-Benzopyran-4-One | CAS: | 1031206-36-6 | MF: | C18H16O4 | MW: | 296.32 | EINECS: | | Product Categories: | | Mol File: | 1031206-36-6.mol | |
| 3-[1-(3-Hydroxy-4-methoxyphenyl)-meth-(E)-ylidene]-6-methyl-chroman-4-one Chemical Properties |
Boiling point | 535.7±50.0 °C(Predicted) | density | 1.286±0.06 g/cm3(Predicted) | storage temp. | room temp | solubility | DMSO: >20mg/mL | form | solid | pka | 9.39±0.10(Predicted) | color | white to off-white |
Hazard Codes | N | Risk Statements | 50/53 | Safety Statements | 60-61 | RIDADR | UN 3077 9 / PGIII | WGK Germany | 3 |
| 3-[1-(3-Hydroxy-4-methoxyphenyl)-meth-(E)-ylidene]-6-methyl-chroman-4-one Usage And Synthesis |
Uses | IMS2186 is an anti-prileferative and anti-angiogenic compound. |
| 3-[1-(3-Hydroxy-4-methoxyphenyl)-meth-(E)-ylidene]-6-methyl-chroman-4-one Preparation Products And Raw materials |
|